首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1547357

全球医用大麻市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Medical Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球医用大麻市场需求预计将从 2023 年的 189.7 亿美元达到近 234 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 2.36%。

医用大麻是指利用大麻植物或其衍生物来治疗疾病症状和其他病症。它通常用于缓解慢性疼痛、减少化疗引起的噁心和呕吐、刺激爱滋病患者的食慾，以及治疗多发性硬化症的痉挛。它含有 THC 和 CBD 等大麻素，与人体的内源性大麻素系统相互作用以提供治疗作用。不同地区医用大麻使用的合法化和监管差异很大，反映了不同的社会态度和政府对其使用的政策。

市场动态

人们对大麻治疗功效的日益认可是医用大麻市场的主要动力。研究和临床研究已证明其在治疗癫痫、慢性疼痛和多发性硬化症等多种疾病方面的功效，从而在市场上得到更广泛的接受和采用。各地区医用大麻的逐步合法化和监管审批正在显着提振市场。随着越来越多的国家和州将其用于医疗目的合法化，市场持续成长。此外，患者和医疗保健提供者对大麻潜在健康益处的认识不断提高，正在推动市场成长。关于大麻治疗用途的教育和资讯传播的增加正在鼓励更多患者寻求大麻治疗。此外，种植和萃取技术的进步正在提高大麻产品的品质和一致性，增强其吸引力和可靠性。这些创新使得标准化和高效大麻产品的生产成为可能，并满足医学界的严格要求。此外，製药公司对医用大麻领域的投资和参与不断增加，透过支持研究、产品开发和分销管道，有助于市场成长。然而，监管障碍和法律复杂性可能会阻碍未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球医用大麻市场的每个细分市场进行了包容性评估。医用大麻产业的成长和趋势为本研究提供了整体方法。

市场区隔

医用大麻市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依产品类型

花
油和酊剂

按申请

癌症
慢性疼痛
忧郁和焦虑
关节炎
糖尿病
青光眼
偏头痛
癫痫
多发性硬化症
爱滋病
肌萎缩侧索硬化症
阿兹海默症
创伤后压力症候群（PTSD）
帕金森氏症
抽动秽语症
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医用大麻市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医用大麻市场的主要参与者包括 Tilray、Aurora Cannabis、顶篷 Growth Corporation、Aphria Inc.、Maricann Group Inc.、Tikun Olam Ltd.、MedReleaf。 Corp.、GW Pharmaceuticals Plc.、Cannabis Sativa Inc.、Medical Marijuana Inc.。新产品开发、新产品发布和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：医用大麻公司的竞争格局

医用大麻市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Tilray

公司概况
公司收入
产品
最新动态

Aurora Cannabis

公司概况
公司收入
产品
最新动态

Canopy Growth Corporation

公司概况
公司收入
产品
最新动态

Aphria Inc.

公司概况
公司收入
产品
最新动态

Maricann Group Inc.

公司概况
公司收入
产品
最新动态

Tikun Olam Ltd.

公司概况
公司收入
产品
最新动态

MedReleaf. Corp.

公司概况
公司收入
产品
最新动态

GW Pharmaceuticals Plc.

公司概况
公司收入
产品
最新动态

Cannabis Sativa Inc.

公司概况
公司收入
产品
最新动态

Medical Marijuana Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215864

The global demand for Medical Marijuana Market is presumed to reach the market size of nearly USD 23.4 Billion by 2032 from USD 18.97 Billion in 2023 with a CAGR of 2.36% under the study period 2024-2032.

Medical marijuana denotes the utilization of the cannabis plant or its derivatives to treat symptoms of illness and other conditions. It is often prescribed to alleviate chronic pain, lower nausea, and vomiting concerned with chemotherapy, stimulate appetite in patients with AIDS, and treat spasticity in multiple sclerosis. It contains cannabinoids such as THC and CBD, which interact with the body's endocannabinoid system to provide therapeutic effects. The legalization and regulation of medical marijuana use vary widely across different regions, reflecting differing societal attitudes and governmental policies toward its use.

MARKET DYNAMICS

The rising recognition of the therapeutic benefits of marijuana is a major driving medical marijuana market. Research and clinical studies have demonstrated its efficacy in treating numerous medical conditions, such as epilepsy, chronic pain, and multiple sclerosis, leading to wider acceptance and adoption in the market. The progressive legalization and regulatory approval of medical marijuana in various regions are significantly boosting the market. As more countries and states legalize its use for medical purposes, the market continues to rise. Additionally, the rising awareness among patients & healthcare providers about the potential health benefits of marijuana is driving market growth. Increased education and information dissemination about its therapeutic uses are encouraging more patients to seek marijuana treatments. Furthermore, advancements in cultivation and extraction technologies are improving the quality and consistency of marijuana products, enhancing their appeal and reliability. These innovations are enabling the production of standardized and high-potency marijuana products, meeting the stringent requirements of the medical community. Moreover, pharmaceutical companies' increasing investment and involvement in the medical marijuana sector contribute to market growth by supporting research, product development, and distribution channels. However, regulatory hurdles and legal complexities may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Marijuana. The growth and trends of Medical Marijuana industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Medical Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Flower
Oil & Tinctures

By Application

Cancer
Chronic Pain
Depression and Anxiety
Arthritis
Diabetes
Glaucoma
Migraines
Epilepsy
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Alzheimer's Disease
Post-Traumatic Stress Disorder (PTSD)
Parkinson's Disease
Tourettes
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Marijuana market include Tilray, Aurora Cannabis, Canopy Growth Corporation, Aphria Inc., Maricann Group Inc., Tikun Olam Ltd., MedReleaf. Corp., GW Pharmaceuticals Plc., Cannabis Sativa Inc., Medical Marijuana Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MEDICAL MARIJUANA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Flower Historic and Forecast Sales By Regions
5.4. Oil & Tinctures Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cancer Historic and Forecast Sales By Regions
6.4. Chronic Pain Historic and Forecast Sales By Regions
6.5. Depression and Anxiety Historic and Forecast Sales By Regions
6.6. Arthritis Historic and Forecast Sales By Regions
6.7. Diabetes Historic and Forecast Sales By Regions
6.8. Glaucoma Historic and Forecast Sales By Regions
6.9. Migraines Historic and Forecast Sales By Regions
6.10. Epilepsy Historic and Forecast Sales By Regions
6.11. Multiple Sclerosis Historic and Forecast Sales By Regions
6.12. AIDS Historic and Forecast Sales By Regions
6.13. Amyotrophic Lateral Sclerosis Historic and Forecast Sales By Regions
6.14. Alzheimer's Disease Historic and Forecast Sales By Regions
6.15. Post-Traumatic Stress Disorder (PTSD) Historic and Forecast Sales By Regions
6.16. Parkinson's Disease Historic and Forecast Sales By Regions
6.17. Tourettes Historic and Forecast Sales By Regions
6.18. Others Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL MARIJUANA MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MEDICAL MARIJUANA COMPANIES

8.1. Medical Marijuana Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF MEDICAL MARIJUANA INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Tilray
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Aurora Cannabis
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Canopy Growth Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Aphria Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Maricann Group Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Tikun Olam Ltd.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. MedReleaf. Corp.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. GW Pharmaceuticals Plc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Cannabis Sativa Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Medical Marijuana Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments